Introduction
Rapidly accumulating evidence suggests that the glutamatergic system plays an important role in the neuropathology and treatment of major depressive disorder (MDD) (see Hashimoto, 2009 for review). We had previously reported altered protein expression of specific subunits of the N-methyl-D-aspartate receptor (NMDAR) in the prefrontal cortex (Feyissa et al., 2009) , locus coeruleus (Karolewicz et al., 2005) , and amygdala (Karolewicz et al., 2009b) from depressed subjects compared with healthy controls. These findings coincide with reports showing that NMDAR antagonists exhibit rapid and robust antidepressant effects in treatment resistant depression (Berman et al., 2000; Zarate et al., 2006) . Recent discoveries of selective agonists/antagonists to the various metabotropic glutamate receptors (mGluRs) that exhibit antidepressant-like activity in animal screening procedures provide promising avenues for the discovery of new and improved antidepressant medications (see Palucha and Pilc, 2007; Pilc et al., 2008 for reviews). To date, eight mGluR subtypes (mGluR1-mGluR8) have been described in the mammalian brain and are classified into three groups with respect to their sequence homology, neuronal signaling, and pharmacological properties (Conn and Pin, 1997) . Group I mGluRs (mGluR1and mGluR5) are positively linked to phospholipase C and in general function to enhance glutamate excitations. In contrast, group II (mGluR2, mGluR3) and group III (mGluR4, mGluR6, mGluR7, mGluR8) are negatively coupled to adenylyl cyclase, and thereby negatively modulate excitatory neurotransmitter efflux and neuronal excitability when activated. Group II mGluRs such as mGluR2 and mGluR3 share significant sequence homology and are widely distributed throughout the CNS, with high expression in brain regions (e.g., hippocampus, prefrontal cortex, and amygdala) implicated in MDD (Drevets, 2000) . The function of mGluR2/3 in modulating glutamate neurotransmission, by sensing glutamate spillover and regulating transmitter release, makes them extremely interesting targets for antidepressant Progress in Neuro-Psychopharmacology & Biological Psychiatry 34 (2010) 
